ArchiMed’s Piccoli joins Keensight as senior analyst

Piccoli's private equity career began at Cordusio Società Fiduciaria, where he worked on the regularisation of Italian funds between April and July 2010.

In January 2011, he was recruited as a healthcare, social media and renewables analyst by Hamilton Ventures. In July 2012, he joined Ardian's small-cap team and was involved in fundraising for the GP's third expansion fund.

In January 2013, he began working as a healthcare analyst at listed GP 3i Group. In mid-2014, when 3i's healthcare team spun out and rebranded as ArchiMed, Piccoli joined the new firm alongside fellow co-founders Denis Ribon, Vincent Guillaumot and Cédric Berger.

Last May, Alexandre Carrot and Guillaume Lefebvre, who had both joined Keensight in June 2014, were promoted to chief financial officer and associate, respectively.

Three months later, Jaana Grüter, formerly an analyst at Rothschild's Five Arrows Principal Investments team, left the firm to join Keensight as an analyst.

Having made a 12x money multiple on the sale of spinal implant designer LDR Medical, Keensight currently holds a stake in a single healthcare company, Menix Group. The business, a prostheses designer owned alongside LBO Partners and Turenne, bolted on peer OneOrtho-Medical last summer.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• France
• France
• Keensight Capital
• 3i